Sabinsa’s sister company Sami Labs entered into a Memorandum of Understanding with India’s premier Ayurvedic practice and research organization, Arya Vaidya Sala, Kottakkal (AVS), to further the use of modern scientific methods and technology in exploring more deeply the knowledge base of Ayurveda, with the ultimate goal of improving the health of mankind.
Muhammed Majeed, PhD, founded Sabinsa & Sami Labs based upon his long-held belief that aspects of his native country’s traditional medical system, Ayurveda, could address many of the health issues plaguing society. Because Dr. Majeed and his robust R&D team have found specific benefits that are not always traditional, the company today holds 90 patents worldwide. Sabinsa’s branded ingredients are natural extracts and phytonutrients derived from botanicals with a long history of traditional food, medicinal and cosmetic use, validated by modern scientific studies.
“We are honored by this recognition for the validity of the pioneering work that we have been relentlessly pursuing for the past 26 years in manufacturing and marketing standardized medicinal plant preparations in a manner acceptable to the developed world,” said Dr. Majeed.
AVS Managing Trustee and Chief Physician Dr. P.K. Warrier stressed the value in incorporating modern scientific methods and technology with the knowledge of Ayurveda in order to provide affordable health care to those members of humanity suffering from ill health.
After several months of discussion between senior management teams at AVS and Sami, the major areas of cooperation have been identified as:
- Marketing of AVS products by Sabinsa-Sami throughout the world
- Co-development of new products
- Development of standardized herbal extracts
- Exploring feasibility of large scale cultivation of essential medicinal plants through contract farming
- Create public awareness and seek Governmental support for efforts to conserve and cultivate endangered medicinal plant species